Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

MARKER THERAPEUTICS, INC Return on Tangible Equity 2010-2025 | MRKR

Current and historical return on tangible equity values for MARKER THERAPEUTICS, INC (MRKR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
MARKER THERAPEUTICS, INC Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.01B $0.01B -96.00%
2024-12-31 $-0.01B $0.02B -83.33%
2024-09-30 $-0.01B $0.01B -83.72%
2024-06-30 $-0.01B $0.01B -75.47%
2024-03-31 $-0.01B $0.01B -32.26%
2023-12-31 $-0.01B $0.01B -48.48%
2023-09-30 $-0.01B $0.02B -50.00%
2023-06-30 $-0.01B $0.02B -66.67%
2023-03-31 $-0.03B $0.02B -114.94%
2022-12-31 $-0.03B $0.02B -112.15%
2022-09-30 $-0.04B $0.02B -109.92%
2022-06-30 $-0.04B $0.03B -102.50%
2022-03-31 $-0.04B $0.04B -88.21%
2021-12-31 $-0.04B $0.04B -72.73%
2021-09-30 $-0.04B $0.05B -76.64%
2021-06-30 $-0.04B $0.06B -74.61%
2021-03-31 $-0.03B $0.07B -75.15%
2020-12-31 $-0.03B $0.03B -84.85%
2020-09-30 $-0.02B $0.03B -64.43%
2020-06-30 $-0.02B $0.04B -53.01%
2020-03-31 $-0.02B $0.04B -48.35%
2019-12-31 $-0.02B $0.04B -42.21%
2019-09-30 $-0.15B $0.05B -284.11%
2019-06-30 $-0.15B $0.05B -361.68%
2019-03-31 $-0.15B $0.06B -500.00%
2018-12-31 $-0.15B $0.06B -910.77%
2018-09-30 $-0.02B $0.00B -600.00%
2018-06-30 $-0.02B $0.00B -400.00%
2018-03-31 $-0.01B $0.00B -240.00%
2017-12-31 $-0.01B $0.00B -191.30%
2017-09-30 $-0.01B $0.01B -160.00%
2017-06-30 $-0.01B $0.01B -123.08%
2017-03-31 $0.00B $0.00B 0.00%
2016-12-31 $0.00B $0.01B 37.50%
2016-09-30 $0.00B $0.01B 20.34%
2016-06-30 $0.03B $-0.02B -120.43%
2016-03-31 $-0.04B $-0.03B 107.04%
2015-12-31 $-0.03B $-0.02B 108.80%
2015-09-30 $-0.03B $-0.03B 121.90%
2015-06-30 $-0.06B $-0.07B 318.99%
2015-03-31 $0.00B $-0.01B 57.14%
2014-12-31 $-0.03B $0.00B 1127.27%
2014-09-30 $-0.03B $0.00B 715.79%
2014-06-30 $-0.03B $0.00B 573.91%
2014-03-31 $-0.04B $-0.01B 560.00%
2013-12-31 $-0.01B $-0.01B 80.00%
2013-09-30 $0.00B $-0.01B 72.73%
2013-06-30 $0.00B $-0.01B 76.19%
2013-03-31 $-0.01B $-0.01B 120.00%
2012-12-31 $-0.01B $-0.01B 155.56%
2012-09-30 $-0.01B $0.00B 133.33%
2012-06-30 $-0.01B $0.00B 153.85%
2012-03-31 $0.00B $0.00B 72.73%
2011-12-31 $0.00B $0.00B 88.89%
2011-09-30 $0.00B $0.00B 80.00%
2011-06-30 $0.00B $0.00B 88.89%
2011-03-31 $0.00B $0.00B 171.43%
2010-12-31 $0.00B $0.00B 266.67%
2010-09-30 $-0.01B $0.00B 1066.67%
2010-06-30 $-0.01B $0.00B 1066.67%
2010-03-31 $-0.01B $0.00B 700.00%
2009-12-31 $-0.01B $0.00B 333.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.021B $0.007B
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment and eradication of cancer, including metastatic cancer. The company's product pipeline consists of MultiTAA T Cell Therapy, TPIV200 and TPIV100/110 which are in clinical stage. Marker Therapeutics Inc., formerly known as TapImmune Inc., is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.377B 32.78
Zoetis (ZTS) United States $74.051B 27.63
Takeda Pharmaceutical (TAK) Japan $48.270B 9.60
Daiichi Sankyo, - (DSNKY) Japan $47.264B 24.22
BeOne Medicines - (ONC) Cayman Islands $28.732B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.880B 0.00
Merck (MKKGY) Germany $17.149B 12.56
Shionogi (SGIOY) Japan $14.717B 14.74
Summit Therapeutics (SMMT) United States $14.541B 0.00
United Therapeutics (UTHR) United States $12.471B 11.03
Neurocrine Biosciences (NBIX) United States $12.289B 42.09
Orion OYJ (ORINY) Finland $10.289B 27.82
IPSEN (IPSEY) France $9.940B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.501B 45.87
Madrigal Pharmaceuticals (MDGL) United States $6.535B 0.00
Grifols, S.A (GRFS) Spain $6.154B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.760B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Catalyst Pharmaceuticals (CPRX) United States $3.099B 10.86
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.438B 13.19
NewAmsterdam Pharma (NAMS) Netherlands $2.302B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.220B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.195B 0.00
Indivior (INDV) United States $1.883B 7.99
Centessa Pharmaceuticals (CNTA) United Kingdom $1.668B 0.00
Dyne Therapeutics (DYN) United States $1.656B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.408B 0.00
Ocular Therapeutix (OCUL) United States $1.405B 0.00
Guardian Pharmacy Services (GRDN) United States $1.276B 0.00
Harrow (HROW) United States $1.160B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Enliven Therapeutics (ELVN) United States $0.962B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.957B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.15
Akebia Therapeutics (AKBA) United States $0.938B 0.00
Ardelyx (ARDX) United States $0.885B 0.00
Cronos Group (CRON) Canada $0.756B 0.00
Elite Pharmaceuticals (ELTP) United States $0.726B 0.00
Xeris Biopharma Holdings (XERS) United States $0.685B 0.00
Xencor (XNCR) United States $0.678B 0.00
KalVista Pharmaceuticals (KALV) United States $0.669B 0.00
AleAnna (ANNA) United States $0.587B 0.00
Relay Therapeutics (RLAY) United States $0.573B 0.00
Verve Therapeutics (VERV) United States $0.570B 0.00
Regulus Therapeutics (RGLS) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Bioventus (BVS) United States $0.551B 13.98
Theravance Biopharma (TBPH) United States $0.531B 0.00
Altimmune (ALT) United States $0.530B 0.00
Zevra Therapeutics (ZVRA) United States $0.513B 0.00
Tourmaline Bio (TRML) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Siga Technologies (SIGA) United States $0.453B 9.46
Organogenesis (ORGO) United States $0.412B 0.00
Savara (SVRA) United States $0.380B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.379B 10.24
Aquestive Therapeutics (AQST) United States $0.339B 0.00
Heron Therapeutics (HRTX) United States $0.314B 0.00
Liminatus Pharma (LIMN) United States $0.289B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
ProKidney (PROK) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.10
Esperion Therapeutics (ESPR) United States $0.240B 0.00
Nanobiotix S.A (NBTX) France $0.239B 0.00
MediWound (MDWD) Israel $0.223B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.198B 0.00
OmniAb (OABI) United States $0.198B 0.00
Aldeyra Therapeutics (ALDX) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.170B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Lyell Immunopharma (LYEL) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.119B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Fractyl Health (GUTS) United States $0.111B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Inotiv (NOTV) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.087B 14.25
Cumberland Pharmaceuticals (CPIX) United States $0.085B 63.00
Nutriband (NTRB) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Jupiter Neurosciences (JUNS) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Prelude Therapeutics (PRLD) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.060B 0.00
PMV Pharmaceuticals (PMVP) United States $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Avalo Therapeutics (AVTX) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
FibroGen (FGEN) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.025B 0.00
Carisma Therapeutics (CARM) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Ainos (AIMD) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00